
Alexander J. Stratigos, MD, discusses the rationale to evaluate cemiplimab-rwlc in locally advanced basal cell carcinoma.

Your AI-Trained Oncology Knowledge Connection!


Alexander J. Stratigos, MD, discusses the rationale to evaluate cemiplimab-rwlc in locally advanced basal cell carcinoma.

Alexander J. Stratigos, MD, University of Athens Medical School, discusses prevention techniques for melanoma.

Published: September 18th 2020 | Updated:

Published: June 29th 2017 | Updated: